{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:27:21Z","timestamp":1789208841476,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.taap.2011.08.009","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T01:06:04Z","timestamp":1313370364000},"page":"418-424","source":"Crossref","is-referenced-by-count":69,"title":["Role of paraoxonase 1 (PON1) in organophosphate metabolism: Implications in neurodegenerative diseases"],"prefix":"10.1016","volume":"256","author":[{"given":"Vasilis P.","family":"Androutsopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kanavouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristidis M.","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2011.08.009_bb0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000022868","article-title":"Gln\u2192Arg 191 polymorphism of paraoxonase and Parkinson's disease","volume":"49","author":"Akhmedova","year":"1999","journal-title":"Hum. Hered."},{"key":"10.1016\/j.taap.2011.08.009_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-510X(01)00439-7","article-title":"Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease","volume":"184","author":"Akhmedova","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.taap.2011.08.009_bb0020","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1471-4159.2006.03937.x","article-title":"Gene\u2013environment interactions in sporadic Parkinson's disease","volume":"97","author":"BenMoyal-Segal","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2011.08.009_bb0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1096\/fj.04-2106fje","article-title":"Acetylcholinesterase\/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease","volume":"19","author":"BenMoyal-Segal","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.taap.2011.08.009_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2011.08.009_bb0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/mds.10172","article-title":"Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease","volume":"17","author":"Carmine","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.taap.2011.08.009_bb0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neulet.2006.08.074","article-title":"Association analysis of the paraoxonase-1 gene with Alzheimer's disease","volume":"408","author":"Cellini","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2011.08.009_bb0045","doi-asserted-by":"crossref","first-page":"12639","DOI":"10.1073\/pnas.0807062105","article-title":"PON1 multitasks to protect health","volume":"105","author":"Chambers","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.taap.2011.08.009_bb0050","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/hmg\/ddp059","article-title":"A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis","volume":"18","author":"Chi\u00f2","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.taap.2011.08.009_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2004.05.108","article-title":"Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finish population","volume":"367","author":"Clarimon","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2011.08.009_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0041-008X(90)90263-T","article-title":"Serum paraoxonase and its influence on paraoxon and chlorpyrifos oxon toxicity in rats","volume":"76","author":"Costa","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2011.08.009_bb0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.med.54.101601.152421","article-title":"Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease and drug metabolism","volume":"54","author":"Costa","year":"2003","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.taap.2011.08.009_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.09.019","article-title":"Measurement of paraoxonase status as a potential biomarker of susceptibility to organophosphate toxicity","volume":"352","author":"Costa","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.taap.2011.08.009_bb0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2004.08.027","article-title":"Modulation of paraoxonase (PON1) activity","volume":"69","author":"Costa","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2011.08.009_bb0080","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/jnnp.2006.112581","article-title":"Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis","volume":"78","author":"Cronin","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.taap.2011.08.009_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1749-6632.2002.tb04821.x","article-title":"Paraoxonase 1 192\/55 gene polymorphisms in Alzheimer's disease","volume":"977","author":"Dantoine","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.taap.2011.08.009_bb0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/WNR.0b013e32831af220","article-title":"Interaction between PON1 and population density in amyotrophic lateral sclerosis","volume":"20","author":"Diekstra","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.taap.2011.08.009_bb0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2011.08.009_bb0100","first-page":"101","article-title":"Biotransformation enzyme polymorphism and pesticide susceptibility","volume":"21","author":"Eaton","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2011.08.009_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/hmg\/ddi428","article-title":"Polymorphisms in the PON gene cluster are associated with Alzheimer disease","volume":"15","author":"Erlich","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.taap.2011.08.009_bb0110","unstructured":"Erlich, P.M., Lunetta, K.L., Cupples, L.A., Abraham, C.R., Green, R.C., Baldwin, C.T., Farrer, L.A., Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease. Neurobiol. Aging."},{"key":"10.1016\/j.taap.2011.08.009_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archneur.62.1.91","article-title":"Pesticides and risk of Parkinson disease: a population-based case\u2013control study","volume":"62","author":"Firestone","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.taap.2011.08.009_bb0120","first-page":"55","article-title":"Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease","volume":"14","author":"Fong","year":"2005","journal-title":"Acta Neurol. Taiwan"},{"key":"10.1016\/j.taap.2011.08.009_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jbt.20181","article-title":"Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorous compounds","volume":"21","author":"Furlong","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.taap.2011.08.009_bb0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuro.2004.08.002","article-title":"Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants","volume":"26","author":"Furlong","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2011.08.009_bb0135","first-page":"361","article-title":"Paraoxonases: structure, gene polymorphism & role in coronary artery disease","volume":"130","author":"Gupta","year":"2009","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.taap.2011.08.009_bb0150","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00029330-200607020-00013","article-title":"Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer's disease in a Chinese Han ethnic population","volume":"119","author":"He","year":"2006","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.taap.2011.08.009_bb0155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1017\/S0317167100052835","article-title":"A case\u2013control study of Parkinson's disease in urban populations of southern Israel","volume":"28","author":"Herishanu","year":"2001","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.taap.2011.08.009_bb0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000323265","article-title":"Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression","volume":"8","author":"Ikeda","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.taap.2011.08.009_bb0165","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1289\/ehp.7135","article-title":"Association of pesticide exposure with neurologic dysfunction and disease","volume":"112","author":"Kamel","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2011.08.009_bb0170","unstructured":"Kanavouras, K., Tzatzarakis, M.N., Mastorodemos, V., Plaitakis, A., Plaitakis, A., Tsatsakis, A.M., in press. A case report of motor neuron disease in a patient showing significant level of DDTs, HCHs and organophosphate metabolites in hair as well levels of hexane and toluene in blood. Toxicol. Appl."},{"issue":"130","key":"10.1016\/j.taap.2011.08.009_bb0175","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/brain\/awm055","article-title":"Large-scale pathways-based association study in amyotrophic lateral sclerosis","volume":"2007","author":"Kasperaviciute","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.taap.2011.08.009_bb0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/30741","article-title":"Acute stress facilitates long-lasting changes in cholinergic gene expression","volume":"393","author":"Kaufer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.taap.2011.08.009_bb0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jnnp.74.4.546","article-title":"Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease","volume":"74","author":"Kelada","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.taap.2011.08.009_bb0195","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/17482960802233177","article-title":"A common haplotype within the PON1 promoter region is associated with sporadic ALS","volume":"9","author":"Landers","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.taap.2011.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2011.08.009_bb0205","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0753-3322(99)80077-8","article-title":"Pesticides and Parkinson's disease","volume":"53","author":"Le Couteur","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2011.08.009_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000113709","article-title":"Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels","volume":"5","author":"Leduc","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.taap.2011.08.009_bb0215","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1460-9568.2009.06983.x","article-title":"Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology","volume":"30","author":"Leduc","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.taap.2011.08.009_bb0335","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00109-003-0481-4","article-title":"Paraoxonase gene polymorphisms, oxidative stress, and diseases","volume":"81","author":"Li","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.taap.2011.08.009_bb0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-4274(95)80006-Y","article-title":"Paraoxonase protects against chlorpyrifos toxicity in mice","volume":"76","author":"Li","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2011.08.009_bb0225","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00008571-200012000-00002","article-title":"Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates","volume":"10","author":"Li","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.taap.2011.08.009_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.bjp.0701390","article-title":"Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon","volume":"122","author":"Mackness","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2011.08.009_bb0235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/EDE.0b013e3181c15ec6","article-title":"Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease","volume":"21","author":"Manthripragada","year":"2010","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.taap.2011.08.009_bb0240","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.neuro.2006.11.007","article-title":"A gene\u2013environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis","volume":"28","author":"Morahan","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2011.08.009_bb0245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2003.05.011","article-title":"PON1M\/L55M mutation protects high-risk patients against coronary artery disease","volume":"94","author":"Oliveira","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.taap.2011.08.009_bb0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000067975","article-title":"Lack of association between Alzheimer's disease and Gln-Arg 192 Q\/R polymorphism of the PON-1 gene in an Italian population","volume":"15","author":"Pola","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.taap.2011.08.009_bb0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neulet.2005.03.027","article-title":"Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q\/R polymorphism of the PON-1 gene","volume":"382","author":"Pola","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.taap.2011.08.009_bb0260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/01.wnl.0000227187.52002.88","article-title":"Paraoxonase cluster polymorphisms are associated with sporadic ALS","volume":"67","author":"Saeed","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2011.08.009_bb0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.taap.2011.08.009_bb0345","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1212\/01.wnl.0000219565.32247.11","article-title":"Paraoxonase gene polymorphisms and sporadic ALS","volume":"67","author":"Slowik","year":"2006","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.taap.2011.08.009_bb0265","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/17482960802455416","article-title":"Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review","volume":"10","author":"Sutedja","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.taap.2011.08.009_bb0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ana.21993","volume":"68","author":"Ticozzi","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.taap.2011.08.009_bb0275","first-page":"101","article-title":"Experiences with acute organophosphate poisonings in Crete","volume":"38","author":"Tsatsakis","year":"1996","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.taap.2011.08.009_bb0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.toxlet.2008.10.018","article-title":"Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross sectional study of a Greek rural population professionally exposed to pesticides","volume":"186","author":"Tsatsakis","year":"2009","journal-title":"Toxicol. Lett."},{"issue":"10","key":"10.1016\/j.taap.2011.08.009_bb0285","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3109\/00498254.2011.590545","article-title":"Associations of xenobiotic-metabolizing enzyme-genotypes PON1Q192R, PON1L55M AND CYP1A1*2A MspI with pathological symptoms of a rural population in south Greece","volume":"41","author":"Tsatsakis","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2011.08.009_bb0290","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/cbf.1519","article-title":"The relationship of oral disturbances of diabetes mellitus patients with paraoxonase gene polymorphisms","volume":"26","author":"Unur","year":"2008","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.taap.2011.08.009_bb0295","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/01.wnl.0000324997.21272.0c","article-title":"Association of paraoxonase gene cluster. Polymorphisms with ALS in France, Quebec, and Sweden","volume":"71","author":"Valdmanis","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2011.08.009_bb0300","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng.442","article-title":"Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis","volume":"41","author":"van Es","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2011.08.009_bb0305","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/01.wnl.0000305956.37931.dd","article-title":"Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS","volume":"70","author":"Wills","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2011.08.009_bb0310","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.0b013e3181a18674","article-title":"A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS","volume":"73","author":"Wills","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2011.08.009_bb0315","unstructured":"Wingo, T.S., Rosen, A., Cutler, D.J., Lah, J.J., Levey, A.I., in press. Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases. Neurobiol. Ag."},{"key":"10.1016\/j.taap.2011.08.009_bb0320","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1194\/jlr.P004960","article-title":"Paraoxonase 1 R\/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue","volume":"51","author":"Zafiropoulos","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2011.08.009_bb0325","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0028-3843(14)60038-4","article-title":"The -A162G polymorphism of the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis","volume":"44","author":"Zawi\u015blak","year":"2010","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.taap.2011.08.009_bb0330","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10038-004-0176-x","article-title":"Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis","volume":"49","author":"Zintzaras","year":"2004","journal-title":"J. Hum. Genet."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11003073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X11003073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T02:06:31Z","timestamp":1560477991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X11003073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0041008X11003073"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2011.08.009","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}